Latest agbiotech News

Launch of new Queensland-based research and manufacturing hub targeting precision medicines
Novartis, Monash University and Monash Health partner for heart
Cell & Gene Catalyst champions industry at BioKorea 2024
CUREator deploys $7.21 Million to propel local life sciences potential
PolyNovo announces appointment of general counsel and company secretary
TGA Seeks Applicants For Statutory Advisory Committees
Industry applauds $18.8m funding for National One Stop Shop for clinical trials
Mesoblast Announces Appointment Of New Board Chair
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
AusMedtechInvest Keynote And Panel Speakers Announced
Mark Butler announces NHMRC funding for six telehealth research projects
Tour de Cure backs further development of Noxopharm’s preclinical brain cancer candidate
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
AusBiotech Announces Incoming CEO
Immutep appoints research institute to conduct first-in-human study of IMP761
Telix Pharmaceuticals records another quarter of strong revenue growth
AusBiotech Submits Response On NSW Innovation Blueprint
Next Science says study shows efficacy in reducing infection when used in knee arthroplasty
Telix’s TLX101-CDx granted fast track designation by US FDA
First Turkish patient treated with OncoSil cancer treatment device
AusBiotech Welcomes Medical Science Co-Investment Plan
Starpharma partners with UK investment firm to create Petalion Therapeutics
Opthea Appoints Sujal Shah To Its Board Of Directors
Percheron Therapeutics provides update on ATL1102 Duchenne muscular dystrophy trial
Imugene’s oncolytic virotherapy CF33 patent granted in China
Sponsors Given Opportunity To Review Proposed Benefits
Optiscan Imaging announces the appointment of US clinical and regulatory heads
Call for sessions and speakers for Australia’s biggest week in biotech
AusMedtech 2024 Programme Launched
Orthocell completes all nerve repair surgeries in Remplir US market authorisation study
Cochlear announces the resignation of non-executive director Yasmin Allen AM
Clarity Pharmaceuticals launches $121 million fully underwritten equity raising
‘Reaching this point in the development of bisantrene is a major milestone and accomplishment’
Applications open for Moderna’s 2024 Australia Fellowship Program
Cell & Gene Catalyst submits feedback on HTA consultation
Telix announces QDOSE platform partnership for personalised dosimetry in radiopharmaceutical therapy
CSIRO announces the appointment of new Australian Centre for Disease Preparedness director
LBT Innovations announces that its APAS PharmaQC product is commercially ready
Dimerix raises $20 million to continue and expand late-stage clinical trial of DMX-200
Anteris Technologies welcomes updated DurAVR THV for serious heart condition
Mesoblast says US FDA feedback indicates support for accelerated approval pathway
Clarity Pharmaceuticals says SAR-bisPSMA detects PC lesions in the 2-millimetre range
Proteomics International retains its ISO 13485 certification
‘Innovations in equality’ highlighted on International Women’s Day
AdAlta announces positive results from Phase 1 extension study of lead asset AD-214
Telix announces major acquisition of Canadian-based ARTMS
Invion announces positive results from pre-clinical study of INV043